English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Thursday, July 9, 2020
エーザイとMSD、切除不能肝細胞がんに対する一次療法としてのレンバチニブとペムブロリズマブの併用療法に関し、米国FDAより審査完了通知を受領
11:00 HKT/SGT
TOYOTA、カローラシリーズに「力強さ」と「機能性」を兼ね備えた新型コンパクトSUV「カローラ クロス」を追加、タイで世界初公開
10:00 HKT/SGT
"Corolla Meets SUV"--Toyota Unveils Corolla Cross in Thailand, The New Compact SUV with Strength and Functionality to the Corolla Series
09:59 HKT/SGT
Emerge 2020 HR Tech Summit Concluded Successfully
08:03 HKT/SGT
香港國安法:中國國安部稱將配合駐港國安公署履行職權
07:00 HKT/SGT
香港國安法:中國國安部稱將配合駐港國安公署履行職權
06:00 HKT/SGT
Advanced "YES UA" Mobile APP supports instant verification with New Smart ID Cards
06:00 HKT/SGT
HKTDC Entrepreneur Day / Education & Careers Expo open 16 July
05:00 HKT/SGT
아방스 클리니컬, 프로스트 앤 설리번의 “2020 아시아태평양 CRO 시장 리더십 어워즈” 수상
00:30 HKT/SGT
Avance Clinical榮獲Frost & Sullivan 2020亞太CRO市場領導力獎
00:30 HKT/SGT
Avance Clinical荣获Frost & Sullivan“2020亚太CRO市场领导力奖”
00:30 HKT/SGT
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
00:30 HKT/SGT
Wednesday, July 8, 2020
Los Angeles Digital Marketing Agency Scores U.S. National Success
20:00 HKT/SGT
Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards
18:45 HKT/SGT
「冠君创业营商实战计划」反应踊跃 商界领袖齐分享成功之道
18:32 HKT/SGT
「冠君創業營商實戰計劃」反應踴躍 商界領袖齊分享成功之道
18:31 HKT/SGT
"The Real Champion - Entrepreneur in Action" Receives Overwhelming Responses Business Leaders Share Pathways to Success
18:30 HKT/SGT
ソニー、ズーム全域開放F値2.8の明るさで世界最広角12mmを実現した大口径超広角ズームレンズを発売
16:00 HKT/SGT
NEC、リスボン市民向け情報共有アプリ「Lisboa.24」をリスボン市と共同開発
16:00 HKT/SGT
天宸康合資產管理:海普瑞(09989-HK)長期發展潛力巨大 可以關注
14:48 HKT/SGT
研發強勁全球市場份額領先 海普瑞今敲鑼上市
14:26 HKT/SGT
エーザイ、自社創製の新規不眠症治療薬「DAYVIGO(R)」が香港において新薬承認申請受理
14:00 HKT/SGT
Eisai: New Drug Application for In-House Developed New Anti-insomnia Drug Dayvigo Accepted in Hong Kong
13:33 HKT/SGT
エーザイ、抗がん剤タゼメトスタットについて日本においてEZH2遺伝子変異陽性の濾胞性リンパ腫に係る適応で新薬承認申請書を提出
13:30 HKT/SGT
Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tazemetostat for EZH2 Gene Mutation-Positive Follicular Lymphoma
13:16 HKT/SGT
APE Introduces Full-range Electronic Gaming Equipment to New Integrated Resort Hoiana in Vietnam
13:00 HKT/SGT
這波港股打新中,找個價值窪地:推虎視
12:09 HKT/SGT
这波港股打新中,找个价值洼地:推虎视
12:08 HKT/SGT
讓人看到真實的香港!《香港,請再次閃耀》獲國際大獎
11:55 HKT/SGT
弘阳地产获克而瑞证券发表「强烈推荐」研究报告
11:46 HKT/SGT
弘陽地產獲克而瑞證券發表「強烈推薦」研究報告
11:45 HKT/SGT
LIVE BOARDと富士通、新たな屋内広告配信サービスの基盤となる、広告視認数に応じたインプレッション計測モデルを構築
11:00 HKT/SGT
AIM ImmunoTech、国立感染症研究所および塩野義製薬とCOVID-19のワクチンアジュバント候補としてのAmpligenの試験に関する物質移動・研究契約を締結
08:00 HKT/SGT
AIM ImmunoTech(AIM)與日本國立傳染病研究所及全球領先的製藥公司Shionogi簽署傳質和研究協議,以測試擴增素是否可作為COVID-19的潛在疫苗佐劑
08:00 HKT/SGT
AIM ImmunoTech(AIM)与日本国立传染病研究所及全球领先的制药公司Shionogi签署传质和研究协议,以测试扩增素是否可作为COVID-19的潜在疫苗佐剂
08:00 HKT/SGT
Tuesday, July 7, 2020
Tonaquint completes acquisition of Fiberpipe Data Centers
23:20 HKT/SGT
华融金控拟换股私有化华融投资 双赢整合实行「投资+投行」战略
19:20 HKT/SGT
華融金控擬換股私有化華融投資 雙贏整合實行「投資+投行」戰略
19:19 HKT/SGT
亚洲先锋娱乐将全方位电子博彩设备引入越南全新综合度假村「会安南岸」(Hoiana)
19:12 HKT/SGT
亞洲先鋒娛樂將全方位電子博彩設備引入越南全新綜合度假村「會安南岸」(Hoiana)
19:11 HKT/SGT
敏捷银行转型成效显著 渤海银行资产质量良好
18:28 HKT/SGT
敏捷銀行轉型成效顯著 渤海銀行資產質量良好
18:27 HKT/SGT
全新升級「YES UA」手機APP 支援認證新版香港智能身份證
17:00 HKT/SGT
創新藥市場廣闊 海普瑞發展可期
16:00 HKT/SGT
Suprema Intelligent Access Control Solutions Help Maintain Employee and Business Wellness
16:00 HKT/SGT
 ACN Search:
 
Summer Sourcing Weeks | Go Online will feature a wide range of products including lighting, electronics, ICT, medical and healthcare items, houseware, home textiles and furnishings, fashion, gifts and premiums, printing and packaging and more, enabling companies to continue to explore cross-industry business opportunities. See https://ssw.hktdc.com.
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575